Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borenstein Graves, A.
Right arrow Articles by Larson, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borenstein Graves, A.
Right arrow Articles by Larson, E. B.
Related Collections
Right arrow Alzheimer's disease
Neurology 2001;57:1453-1460
© 2001 American Academy of Neurology


Articles

Head circumference and incident Alzheimer’s disease

Modification by apolipoprotein E

A. Borenstein Graves, PhD, J. A. Mortimer, PhD, J. D. Bowen, MD, W. C. McCormick, MD, S. M. McCurry, PhD, G. D. Schellenberg, PhD and E. B. Larson, MD

From the Department of Epidemiology and Biostatistics (Dr. Borenstein Graves) and Institute on Aging (Dr. Mortimer), University of South Florida, Tampa; Departments of Neurology (Dr. Bowen), Medicine (Drs. McCormick and Larson), and Psychosocial and Community Health (Dr. McCurry), University of Washington; and Division of Gerontology and Geriatric Medicine, Veterans Affairs Medical Center, GRECC (Dr. Schellenberg), Seattle, WA.

Address correspondence and reprint requests to Dr. A. Borenstein Graves, Department of Epidemiology and Biostatistics, College of Public Health, MDC-56, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL 33612-3805; e-mail: amgraves{at}hsc.usf.edu

Background: — The clinical expression of AD likely occurs when the accumulation of degeneration in specific brain regions leads to the descent below a critical threshold of "brain reserve" beyond which normal cognitive function cannot be maintained. The association between head circumference (HC), a measure of brain reserve, and the incidence of probable AD was examined in a large nondemented cohort that has been followed since 1992 and its modification by APOE {epsilon}4 genotype.

Methods: — Fifty-nine incident cases of probable AD were identified from 1,869 initially nondemented individuals seen at the baseline examination (1992 to 1994) and followed for a mean of 3.8 years. Variables measured at baseline included age, education, gender, HC, height, weight, and score on the National Adult Reading Test–Revised. APOE was genotyped at the time of the first biennial examination (1994 to 1996) and was available for 1,111 individuals in the cohort. Cox proportional hazard regression was performed to estimate hazard ratios (HR) for probable AD for HC and other covariates.

Results: — Incident cases were significantly older, less educated, shorter, and lighter, had lower estimated verbal IQ scores, and were more likely to have at least one APOE {epsilon}4 allele than unaffected individuals. The HR associated with the lowest tertile of HC (<21.4 inches) adjusted for education, gender, and APOE {epsilon}4 was 2.3 (95% CI 0.7 to 6.9, p = 0.16). The HR for one or two APOE {epsilon}4 alleles was significant (HR = 4.8, 95% CI 1.8 to 12.9, p = 0.002). The combination of low HC and APOE {epsilon}4 strongly predicted earlier onset of AD with HR = 14.1 (95% CI 3.0 to 65, p = 0.0007).

Conclusions: — Smaller HC, in the presence of the APOE {epsilon}4 allele, hastens the age at onset of AD. These results support the brain reserve hypothesis and its importance in precipitating the clinical expression of AD among genetically predisposed individuals.




This article has been cited by other articles:


Home page
NeurologyHome page
J. L. Cummings, R. Doody, and C. Clark
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Neurology, October 16, 2007; 69(16): 1622 - 1634.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Galasko, D. Salmon, A. Gamst, J. Olichney, L. J. Thal, L. Silbert, J. Kaye, P. Brooks, R. Adonay, U.-K Craig, et al.
Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE
Neurology, May 22, 2007; 68(21): 1772 - 1781.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. A. Bennett, J. A. Schneider, Z. Arvanitakis, J. F. Kelly, N. T. Aggarwal, R. C. Shah, and R. S. Wilson
Neuropathology of older persons without cognitive impairment from two community-based studies
Neurology, June 27, 2006; 66(12): 1837 - 1844.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. A. Mortimer, A. R. Borenstein, K. M. Gosche, and D. A. Snowdon
Very Early Detection of Alzheimer Neuropathology and the Role of Brain Reserve in Modifying Its Clinical Expression
J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 218 - 223.
[Abstract] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
F. Beland, M.-V. Zunzunegui, B. Alvarado, A. Otero, and T. del Ser
Trajectories of Cognitive Decline and Social Relations
J. Gerontol. B. Psychol. Sci. Soc. Sci., November 1, 2005; 60(6): P320 - P330.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Mosconi, K Herholz, I Prohovnik, B Nacmias, M T R De Cristofaro, M Fayyaz, L Bracco, S Sorbi, and A Pupi
Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve
J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 15 - 23.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grundman
Weight Loss in the Elderly May Be a Sign of Impending Dementia
Arch Neurol, January 1, 2005; 62(1): 20 - 22.
[Full Text] [PDF]


Home page
BrainHome page
C. R. Gale, S. Walton, and C. N. Martyn
Foetal and postnatal head growth and risk of cognitive decline in old age
Brain, October 1, 2003; 126(10): 2273 - 2278.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. D. Edland, Y. Xu, M. Plevak, P. O'Brien, E. G. Tangalos, R. C. Petersen, and C. R. Jack Jr.
Total intracranial volume: Normative values and lack of association with Alzheimer's disease
Neurology, July 23, 2002; 59(2): 272 - 274.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Gurwitz, J. Chapman, and A. Weizman
Head circumference and incident Alzheimer's disease: Modification by apolipoprotein E
Neurology, May 14, 2002; 58(9): 1440 - 1440.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Head circumference and incident Alzheimer’s disease: Modification by apolipoprotein E
D Gurwitz J Chapman, et al.
Neurology Online, 18 Dec 2001 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.